Diabetic Macular Edema Treatment Market Set to Witness an Uptick During 2017–2025: Persistence Market Research
Diabetic macular edema (DME) is characterized by accumulation of fluid in the macula – a part of retina responsible for vision. Accumulation may cause by leakage of plasma constituents into the surrounding, consequently leading to edema. Diabetic macular edema is one of the leading causes of blindness among diabetic patients and in 2011, it affected almost 12% of type 1 and 28% type 2 diabetic patients in developing countries. The standard treatment for diabetic macular edema is control of blood...
View full press release